Published in Cent Eur J Immunol on December 15, 2014
T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med (2009) 7.11
Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol (2010) 4.92
Eosinophils: biological properties and role in health and disease. Clin Exp Allergy (2008) 3.92
Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med (1999) 2.92
IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol (2008) 2.83
Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood (2007) 2.20
Effects of anticytokine therapy in a mouse model of chronic asthma. Am J Respir Crit Care Med (2004) 2.15
The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol (2004) 2.13
Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand. Glycobiology (2005) 2.06
Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy (2002) 2.02
Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood (2003) 1.89
IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol (2010) 1.73
Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med (2009) 1.72
Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun (2009) 1.71
Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy (2008) 1.70
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily. J Biol Chem (2000) 1.59
Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur Respir Rev (2010) 1.56
Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J Immunother (2007) 1.39
What targeting eosinophils has taught us about their role in diseases. J Allergy Clin Immunol (2010) 1.33
Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model. Clin Immunol (2009) 1.31
Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy (2008) 1.26
Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int Immunopharmacol (2006) 1.18
Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b β2-integrin-dependent signaling. Blood (2013) 1.13
Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma. Lab Invest (2000) 1.10
Pathogenesis of murine experimental allergic rhinitis: a study of local and systemic consequences of IL-5 deficiency. J Immunol (2002) 1.06
Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Allergy (2011) 1.03
Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation. Health Technol Assess (2013) 1.01
Pattern-recognition receptors in human eosinophils. Immunology (2012) 1.00
Beneficial effect of anti-interleukin-33 on the murine model of allergic inflammation of the lower airway. J Asthma (2012) 0.90
Eosinophil-mediated tissue inflammatory responses in helminth infection. Korean J Parasitol (2009) 0.89
Targeting interleukin (IL) 5 for asthma and hypereosinophilic diseases. Recent Pat Inflamm Allergy Drug Discov (2010) 0.81
Antiallergic effect of anti-Siglec-F through reduction of eosinophilic inflammation in murine allergic rhinitis. Am J Rhinol Allergy (2013) 0.78
Exposure to hypergravity increases serum interleukin-5 and pulmonary infiltration in mice with allergic asthma. Cent Eur J Immunol (2014) 0.79